Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Olesia Bochar"'
Autor:
Volodymyr T Bochar, Olesia Bochar
Publikováno v:
Scientific Journal of Polonia University. 46:208-214
This research was aimed to estimate the course of hypertension on the background of obesity and nonalcoholic fatty liver disease according to its stages (steatosis and steatohepatitis). Ninety patients were evaluated for anthropometric, general-clini
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86881ee0cb76226a86a11c1ad6264c4a
https://doi.org/10.23856/4627
https://doi.org/10.23856/4627
Autor:
Natalia M Hromnats'ka, Khristina Y Abrahamovych, Olesia Bochar, Helena Y Sklyarova, Eugen Y Sklyarov, Volodymyr T Bochar
Publikováno v:
Wiadomości Lekarskie. 74:313-316
OBJECTIVE The aim: To evaluate anthropometric, hemodynamic parameters, as well as changes in blood and leptin lipid spectrum in children and adults with overweight and obesity. PATIENTS AND METHODS Materials and methods: We examined 68 overweight chi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::567966cd495cc87113ff786c2810d98d
https://doi.org/10.36740/wlek202102126
https://doi.org/10.36740/wlek202102126
Publikováno v:
Bukovinian Medical Herald. 24:86-90
Objective – to study the clinical features of the comorbid course of arterial hypertension (AH) and chronic obstructive pulmonary disease (COPD) in combination with obesity.Material and methods. 45 people were examined and divided in 2 groups, firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a68a13223516071c8fdaad02205702b1
https://doi.org/10.24061/2413-0737.xxiv.2.94.2020.48
https://doi.org/10.24061/2413-0737.xxiv.2.94.2020.48
Autor:
Yurij B Kuzminov, Andrij F Faynyk, Olesia Bochar, Helena Y Sklyarova, Volodymyr T Bochar, Andrij Y Bazylevych
Publikováno v:
Wiadomości Lekarskie. 73:321-324
OBJECTIVE The aim: To evaluate the hemodynamic and echocardiographic parameters, the level of adiponectin and IL-6 in such patients under the influence of therapy with sartans (telmisartan or olmesartan) and atorvastatin 12 weeks later. PATIENTS AND
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::55788c371e68ba6d725b2c2dac03e4c6
https://doi.org/10.36740/wlek202002122
https://doi.org/10.36740/wlek202002122
Publikováno v:
Інфекційні хвороби. :46-53
Мета роботи – узагальнити дані про етіологію, механізм розвитку, клінічні прояви, лабораторну діагностику та принципи лікування хологе
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::745b26d0c36464cbf7457a00fb4de0ee
https://doi.org/10.11603/1681-2727.2019.3.10635
https://doi.org/10.11603/1681-2727.2019.3.10635
Autor:
Olesia Bochar
Publikováno v:
Technology Transfer: Innovative Solutions in Medicine, Pp 3-6 (2020)
The research estimates the state of liver detoxifying function and analyzes the changes in the levels of leptin, adiponectin and interleukin-6 in patients with arterial hypertension in combination with obesity and non-alcoholic fatty liver disease. A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::acb592517060189e8cabeb295aa4e5fc
https://zenodo.org/record/4280853
https://zenodo.org/record/4280853
Autor:
Olesia Bochar
Publikováno v:
Вісник наукових досліджень.
In Ukraine, the structure of the share of total mortality for cardiovascular disease (CVD) accounts for 62.5–63.4 %. In particular, at least 75–80 % of deaths from cardiovascular disease are associated with atherosclerotic blood vessels, namely:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d4d9b0cb7284979ad119c8e60712142
https://doi.org/10.11603/2415-8798.2017.2.7823
https://doi.org/10.11603/2415-8798.2017.2.7823
Autor:
Olha Bondarenko, Tetiana Maksymets, Natalia Karpyshyn, Olesia Bochar, Maria Sorochka, Yevhen Sklyarov
Publikováno v:
Scopus-Elsevier
OBJECTIVE Introduction:Cardiovascular diseases (CVD) are one of the most important medical-biological and social problems in Ukraine and in the world because coronary artery disease (CAD) is a major cause of death and disability. Overweight and obesi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a591e54e7f51832f11919a79b37b0efb
http://www.scopus.com/inward/record.url?eid=2-s2.0-85068459670&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85068459670&partnerID=MN8TOARS